Skip to main content
Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia.
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.
Double trouble for Langerhans cell histiocytosis.
The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
Tumor Thrombus- a Single Center Experience with Tumor Thrombus and Role of Anticoagulation
Response of Patients with Transfusion-Dependent ß-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers.
Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with ß-Thalassemia in the Believe Trial.
Sex Based Differences in Sickle Cell Disease.
Clinical Benefit and Tolerability of Crenolanib in Children with Relapsed Acute Myeloid Leukemia Harboring Treatment Resistant FLT3 ITD and Variant FLT3 TKD Mutations Treated on Compassionate Access.